Vaxcyte PCVX
$ 87.38
1.36%
Quarterly report 2024-Q3
added 11-05-2024
Vaxcyte Cash Flow 2011-2024 | PCVX
Annual Cash Flow Vaxcyte
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-297 M | -171 M | -121 M | -46.6 M | -47.1 M | -30.5 M | - | - | - | - | - | - | - |
Depreciation & Amortization |
3.16 M | 2.58 M | 1.8 M | 1.4 M | 1.23 M | 1.04 M | - | - | - | - | - | - | - |
Accounts Payables |
14.6 M | 9.8 M | 6.76 M | 29.8 M | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Vaxcyte
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -159 M | - | - | - | -47.7 M | - | -105 M | -66.8 M | -27.7 M | - | -70.3 M | -41.9 M | -13.2 M | - | -35.9 M | -22.8 M | -13.6 M | - | -32.7 M | -23.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
1.8 M | 1.4 M | 999 K | - | 800 K | 800 K | 712 K | - | 700 K | 600 K | 582 K | - | 1.34 M | 831 K | 347 K | - | 1.07 M | 739 K | 384 K | - | 900 K | 596 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
18.2 M | 10.5 M | 21.7 M | 14.6 M | 15.7 M | 16.3 M | 11.6 M | 9.8 M | 5.48 M | 7.04 M | 4.8 M | 6.76 M | 25.7 M | 23.7 M | 31.9 M | 29.8 M | 29.8 M | 29.8 M | 29.8 M | 3.38 M | 3.38 M | 3.38 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency